ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Albumin (Human) Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-35R8513
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Albumin Human Market Insights and Forecast to 2028
BUY CHAPTERS

Global Albumin (Human) Market Research Report 2025

Code: QYRE-Auto-35R8513
Report
August 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Behring
Baxter
Grifols S A
Octapharma AG
Zhongsheng Group
Taibang Bio
Shanghai Laishi
Hualan Bio

Albumin (Human) Market Size

The global market for Albumin (Human) was valued at US$ 5556 million in the year 2024 and is projected to reach a revised size of US$ 7529 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Albumin (Human) Market

Albumin (Human) Market

North American market for Albumin (Human) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Albumin (Human) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Albumin (Human) include CSL Behring, Baxter, Grifols, Octapharma, Zhongsheng Group, Taibang Bio, Shanghai Laishi, Hualan Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Albumin (Human), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albumin (Human).
The Albumin (Human) market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Albumin (Human) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albumin (Human) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Albumin (Human) Market Report

Report Metric Details
Report Name Albumin (Human) Market
Accounted market size in year US$ 5556 million
Forecasted market size in 2031 US$ 7529 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injection
  • Freeze-dried Injection
Segment by Application
  • Liver Diseases
  • Kidney Diseases
  • Neoplasm
  • Other Diseases
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Behring, Baxter, Grifols, Octapharma, Zhongsheng Group, Taibang Bio, Shanghai Laishi, Hualan Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Albumin (Human) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Albumin (Human) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Albumin (Human) Market growing?

Ans: The Albumin (Human) Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Albumin (Human) Market size in 2031?

Ans: The Albumin (Human) Market size in 2031 will be US$ 7529 million.

Who are the main players in the Albumin (Human) Market report?

Ans: The main players in the Albumin (Human) Market are CSL Behring, Baxter, Grifols, Octapharma, Zhongsheng Group, Taibang Bio, Shanghai Laishi, Hualan Bio

What are the Application segmentation covered in the Albumin (Human) Market report?

Ans: The Applications covered in the Albumin (Human) Market report are Liver Diseases, Kidney Diseases, Neoplasm, Other Diseases

What are the Type segmentation covered in the Albumin (Human) Market report?

Ans: The Types covered in the Albumin (Human) Market report are Injection, Freeze-dried Injection

1 Albumin (Human) Market Overview
1.1 Product Definition
1.2 Albumin (Human) by Type
1.2.1 Global Albumin (Human) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Freeze-dried Injection
1.3 Albumin (Human) by Application
1.3.1 Global Albumin (Human) Market Value by Application (2024 VS 2031)
1.3.2 Liver Diseases
1.3.3 Kidney Diseases
1.3.4 Neoplasm
1.3.5 Other Diseases
1.4 Global Albumin (Human) Market Size Estimates and Forecasts
1.4.1 Global Albumin (Human) Revenue 2020-2031
1.4.2 Global Albumin (Human) Sales 2020-2031
1.4.3 Global Albumin (Human) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Albumin (Human) Market Competition by Manufacturers
2.1 Global Albumin (Human) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Albumin (Human) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Albumin (Human) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Albumin (Human), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Albumin (Human), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Albumin (Human), Product Type & Application
2.7 Global Key Manufacturers of Albumin (Human), Date of Enter into This Industry
2.8 Global Albumin (Human) Market Competitive Situation and Trends
2.8.1 Global Albumin (Human) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Albumin (Human) Players Market Share by Revenue
2.8.3 Global Albumin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Albumin (Human) Market Scenario by Region
3.1 Global Albumin (Human) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Albumin (Human) Sales by Region: 2020-2031
3.2.1 Global Albumin (Human) Sales by Region: 2020-2025
3.2.2 Global Albumin (Human) Sales by Region: 2026-2031
3.3 Global Albumin (Human) Revenue by Region: 2020-2031
3.3.1 Global Albumin (Human) Revenue by Region: 2020-2025
3.3.2 Global Albumin (Human) Revenue by Region: 2026-2031
3.4 North America Albumin (Human) Market Facts & Figures by Country
3.4.1 North America Albumin (Human) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Albumin (Human) Sales by Country (2020-2031)
3.4.3 North America Albumin (Human) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Albumin (Human) Market Facts & Figures by Country
3.5.1 Europe Albumin (Human) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Albumin (Human) Sales by Country (2020-2031)
3.5.3 Europe Albumin (Human) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Albumin (Human) Market Facts & Figures by Region
3.6.1 Asia Pacific Albumin (Human) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Albumin (Human) Sales by Region (2020-2031)
3.6.3 Asia Pacific Albumin (Human) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Albumin (Human) Market Facts & Figures by Country
3.7.1 Latin America Albumin (Human) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Albumin (Human) Sales by Country (2020-2031)
3.7.3 Latin America Albumin (Human) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Albumin (Human) Market Facts & Figures by Country
3.8.1 Middle East and Africa Albumin (Human) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Albumin (Human) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Albumin (Human) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Albumin (Human) Sales by Type (2020-2031)
4.1.1 Global Albumin (Human) Sales by Type (2020-2025)
4.1.2 Global Albumin (Human) Sales by Type (2026-2031)
4.1.3 Global Albumin (Human) Sales Market Share by Type (2020-2031)
4.2 Global Albumin (Human) Revenue by Type (2020-2031)
4.2.1 Global Albumin (Human) Revenue by Type (2020-2025)
4.2.2 Global Albumin (Human) Revenue by Type (2026-2031)
4.2.3 Global Albumin (Human) Revenue Market Share by Type (2020-2031)
4.3 Global Albumin (Human) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Albumin (Human) Sales by Application (2020-2031)
5.1.1 Global Albumin (Human) Sales by Application (2020-2025)
5.1.2 Global Albumin (Human) Sales by Application (2026-2031)
5.1.3 Global Albumin (Human) Sales Market Share by Application (2020-2031)
5.2 Global Albumin (Human) Revenue by Application (2020-2031)
5.2.1 Global Albumin (Human) Revenue by Application (2020-2025)
5.2.2 Global Albumin (Human) Revenue by Application (2026-2031)
5.2.3 Global Albumin (Human) Revenue Market Share by Application (2020-2031)
5.3 Global Albumin (Human) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Albumin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring Albumin (Human) Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Albumin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Albumin (Human) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Albumin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Grifols Albumin (Human) Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Albumin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Albumin (Human) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Zhongsheng Group
6.5.1 Zhongsheng Group Company Information
6.5.2 Zhongsheng Group Description and Business Overview
6.5.3 Zhongsheng Group Albumin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zhongsheng Group Albumin (Human) Product Portfolio
6.5.5 Zhongsheng Group Recent Developments/Updates
6.6 Taibang Bio
6.6.1 Taibang Bio Company Information
6.6.2 Taibang Bio Description and Business Overview
6.6.3 Taibang Bio Albumin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Taibang Bio Albumin (Human) Product Portfolio
6.6.5 Taibang Bio Recent Developments/Updates
6.7 Shanghai Laishi
6.7.1 Shanghai Laishi Company Information
6.7.2 Shanghai Laishi Description and Business Overview
6.7.3 Shanghai Laishi Albumin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai Laishi Albumin (Human) Product Portfolio
6.7.5 Shanghai Laishi Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Company Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Albumin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hualan Bio Albumin (Human) Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Albumin (Human) Industry Chain Analysis
7.2 Albumin (Human) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Albumin (Human) Production Mode & Process Analysis
7.4 Albumin (Human) Sales and Marketing
7.4.1 Albumin (Human) Sales Channels
7.4.2 Albumin (Human) Distributors
7.5 Albumin (Human) Customer Analysis
8 Albumin (Human) Market Dynamics
8.1 Albumin (Human) Industry Trends
8.2 Albumin (Human) Market Drivers
8.3 Albumin (Human) Market Challenges
8.4 Albumin (Human) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Behring
Baxter
Grifols S A
Octapharma AG
Zhongsheng Group
Taibang Bio
Shanghai Laishi
Hualan Bio
List of Tables
 Table 1. Global Albumin (Human) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Albumin (Human) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Albumin (Human) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Albumin (Human) Sales (K Dose) of Key Manufacturers (2020-2025)
 Table 5. Global Albumin (Human) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Albumin (Human) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Albumin (Human) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Albumin (Human) Average Price (USD/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Albumin (Human), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Albumin (Human), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Albumin (Human), Product Type & Application
 Table 12. Global Key Manufacturers of Albumin (Human), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Albumin (Human) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albumin (Human) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Albumin (Human) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Albumin (Human) Sales by Region (2020-2025) & (K Dose)
 Table 18. Global Albumin (Human) Sales Market Share by Region (2020-2025)
 Table 19. Global Albumin (Human) Sales by Region (2026-2031) & (K Dose)
 Table 20. Global Albumin (Human) Sales Market Share by Region (2026-2031)
 Table 21. Global Albumin (Human) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Albumin (Human) Revenue Market Share by Region (2020-2025)
 Table 23. Global Albumin (Human) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Albumin (Human) Revenue Market Share by Region (2026-2031)
 Table 25. North America Albumin (Human) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Albumin (Human) Sales by Country (2020-2025) & (K Dose)
 Table 27. North America Albumin (Human) Sales by Country (2026-2031) & (K Dose)
 Table 28. North America Albumin (Human) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Albumin (Human) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Albumin (Human) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Albumin (Human) Sales by Country (2020-2025) & (K Dose)
 Table 32. Europe Albumin (Human) Sales by Country (2026-2031) & (K Dose)
 Table 33. Europe Albumin (Human) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Albumin (Human) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Albumin (Human) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Albumin (Human) Sales by Region (2020-2025) & (K Dose)
 Table 37. Asia Pacific Albumin (Human) Sales by Region (2026-2031) & (K Dose)
 Table 38. Asia Pacific Albumin (Human) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Albumin (Human) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Albumin (Human) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Albumin (Human) Sales by Country (2020-2025) & (K Dose)
 Table 42. Latin America Albumin (Human) Sales by Country (2026-2031) & (K Dose)
 Table 43. Latin America Albumin (Human) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Albumin (Human) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Albumin (Human) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Albumin (Human) Sales by Country (2020-2025) & (K Dose)
 Table 47. Middle East and Africa Albumin (Human) Sales by Country (2026-2031) & (K Dose)
 Table 48. Middle East and Africa Albumin (Human) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Albumin (Human) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Albumin (Human) Sales (K Dose) by Type (2020-2025)
 Table 51. Global Albumin (Human) Sales (K Dose) by Type (2026-2031)
 Table 52. Global Albumin (Human) Sales Market Share by Type (2020-2025)
 Table 53. Global Albumin (Human) Sales Market Share by Type (2026-2031)
 Table 54. Global Albumin (Human) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Albumin (Human) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Albumin (Human) Revenue Market Share by Type (2020-2025)
 Table 57. Global Albumin (Human) Revenue Market Share by Type (2026-2031)
 Table 58. Global Albumin (Human) Price (USD/Dose) by Type (2020-2025)
 Table 59. Global Albumin (Human) Price (USD/Dose) by Type (2026-2031)
 Table 60. Global Albumin (Human) Sales (K Dose) by Application (2020-2025)
 Table 61. Global Albumin (Human) Sales (K Dose) by Application (2026-2031)
 Table 62. Global Albumin (Human) Sales Market Share by Application (2020-2025)
 Table 63. Global Albumin (Human) Sales Market Share by Application (2026-2031)
 Table 64. Global Albumin (Human) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Albumin (Human) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Albumin (Human) Revenue Market Share by Application (2020-2025)
 Table 67. Global Albumin (Human) Revenue Market Share by Application (2026-2031)
 Table 68. Global Albumin (Human) Price (USD/Dose) by Application (2020-2025)
 Table 69. Global Albumin (Human) Price (USD/Dose) by Application (2026-2031)
 Table 70. CSL Behring Company Information
 Table 71. CSL Behring Description and Business Overview
 Table 72. CSL Behring Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 73. CSL Behring Albumin (Human) Product
 Table 74. CSL Behring Recent Developments/Updates
 Table 75. Baxter Company Information
 Table 76. Baxter Description and Business Overview
 Table 77. Baxter Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 78. Baxter Albumin (Human) Product
 Table 79. Baxter Recent Developments/Updates
 Table 80. Grifols Company Information
 Table 81. Grifols Description and Business Overview
 Table 82. Grifols Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 83. Grifols Albumin (Human) Product
 Table 84. Grifols Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. Octapharma Albumin (Human) Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. Zhongsheng Group Company Information
 Table 91. Zhongsheng Group Description and Business Overview
 Table 92. Zhongsheng Group Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 93. Zhongsheng Group Albumin (Human) Product
 Table 94. Zhongsheng Group Recent Developments/Updates
 Table 95. Taibang Bio Company Information
 Table 96. Taibang Bio Description and Business Overview
 Table 97. Taibang Bio Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 98. Taibang Bio Albumin (Human) Product
 Table 99. Taibang Bio Recent Developments/Updates
 Table 100. Shanghai Laishi Company Information
 Table 101. Shanghai Laishi Description and Business Overview
 Table 102. Shanghai Laishi Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 103. Shanghai Laishi Albumin (Human) Product
 Table 104. Shanghai Laishi Recent Developments/Updates
 Table 105. Hualan Bio Company Information
 Table 106. Hualan Bio Description and Business Overview
 Table 107. Hualan Bio Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 108. Hualan Bio Albumin (Human) Product
 Table 109. Hualan Bio Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Albumin (Human) Distributors List
 Table 113. Albumin (Human) Customers List
 Table 114. Albumin (Human) Market Trends
 Table 115. Albumin (Human) Market Drivers
 Table 116. Albumin (Human) Market Challenges
 Table 117. Albumin (Human) Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Albumin (Human)
 Figure 2. Global Albumin (Human) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Albumin (Human) Market Share by Type: 2024 & 2031
 Figure 4. Injection Product Picture
 Figure 5. Freeze-dried Injection Product Picture
 Figure 6. Global Albumin (Human) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Albumin (Human) Market Share by Application: 2024 & 2031
 Figure 8. Liver Diseases
 Figure 9. Kidney Diseases
 Figure 10. Neoplasm
 Figure 11. Other Diseases
 Figure 12. Global Albumin (Human) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Albumin (Human) Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Albumin (Human) Sales (2020-2031) & (K Dose)
 Figure 15. Global Albumin (Human) Average Price (USD/Dose) & (2020-2031)
 Figure 16. Albumin (Human) Report Years Considered
 Figure 17. Albumin (Human) Sales Share by Manufacturers in 2024
 Figure 18. Global Albumin (Human) Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Albumin (Human) Players: Market Share by Revenue in Albumin (Human) in 2024
 Figure 20. Albumin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Albumin (Human) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Albumin (Human) Sales Market Share by Country (2020-2031)
 Figure 23. North America Albumin (Human) Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Albumin (Human) Sales Market Share by Country (2020-2031)
 Figure 27. Europe Albumin (Human) Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Albumin (Human) Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Albumin (Human) Revenue Market Share by Region (2020-2031)
 Figure 35. China Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Albumin (Human) Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Albumin (Human) Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Albumin (Human) Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Albumin (Human) Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Albumin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Albumin (Human) by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Albumin (Human) by Type (2020-2031)
 Figure 57. Global Albumin (Human) Price (USD/Dose) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Albumin (Human) by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Albumin (Human) by Application (2020-2031)
 Figure 60. Global Albumin (Human) Price (USD/Dose) by Application (2020-2031)
 Figure 61. Albumin (Human) Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Albumin Antibody Market Research Report 2024
Global Albumin Reagent Market Research Report 2025
Global Human Serum Albumin Test Market Insights Forecast to 2030
Global Human Placental Blood Albumin Market Research Report 2024
Global Human Albumin Solution Market Research Report 2024
Global Recombinant Human Albumin Market Research Report 2024
Global Egg Albumin Market Research Report 2024
Biotinylated Human Serum Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Albumin Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Serum Albumin Injection Market Research Report 2024
Global Albumen Powder Market Research Report 2024
Global Protein Labeling Market Research Report 2025
Global Albumin Pharmaceutical Preparations Market Research Report 2024
Global Plasma derived Human Serum Albumin Test Market Insights Forecast to 2030
Global Human Serum Market Research Report 2024
Global Tocopherol Market Research Report 2024
Global Albumin Testing Market Research Report 2024
Global Protein Powders Market Research Report 2024
Global Human Immunoglobulin Market Research Report 2024
Global Human Immunoassay Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions